Kelly, Sean T.2024-01-112024-01-112017-12http://hdl.handle.net/11603/31268The intent of this proposal is to utilize the rate-limiting catabolism of tryptophan to determine its level of involvement in protein expression as it relates to anti-tumor responses through genetic expression studies and cytokine recruitment assays. Exploring specific cytokine involvement as it relates to lymphomas will contribute a better underlying understanding of the enzyme indoleamine 2, 3-dioxygenase 2 (IDO2) and its involvement in disease development.40 pagesen-USText